Multiomics in Metabolic Disease
Genetic and biological factors significantly influence the risk of metabolic disorders such as obesity, type 2 diabetes, and dyslipidemia. Advances in ‘omics’ technologies—genomics, epigenomics, transcriptomics, [...]